Literature DB >> 18558189

Determination of risk factors for deep venous thrombosis in hospitalized children.

Lan T Vu1, Kerilyn K Nobuhara, Hanmin Lee, Diana L Farmer.   

Abstract

PURPOSE: Our objective was to determine the time trend and risk factors for deep venous thrombosis (DVT) of the lower extremities among pediatric inpatients.
METHODS: This cross-sectional study used the data from the Health Care Cost and Utilization Project Kids' Inpatient Database for the years of 1997, 2000, and 2003 to estimate the DVT prevalence and crude and adjusted prevalence ratios. Patients between the ages of 1 and 17 years and who were hospitalized for at least 4 days were included.
RESULTS: The weighted prevalence of DVT was 4.2 per 1000 hospital discharges (95% confidence interval [CI], 3.4-3.7). Independent of age, the prevalence of DVT was significantly greater in 2000 and 2003 compared to 1997, prevalence ratio (PR) of 1.2 and 1.4 (95% CI, 1.1-1.3 and 1.2-1.4). Using only the 2003 database, adjusted analysis revealed that patients at highest risk were those in the age range of 15 to 17 years (PR, 2.0; 95% CI, 1.6-2.4) and with the following comorbid conditions: obesity (PR, 2.1; 95% CI, 1.5-2.8), inflammatory bowel disease (PR, 1.8; 95% CI, 1.2-2.7), hematologic malignancy (PR, 2.5; 95% CI, 2.0-3.1), and thoracoabdominal (PR, 1.8; 95% CI, 1.6-2.2) or orthopedic (PR, 2.2; 95% CI, 1.7-2.8) operations. Predictors not associated with DVT included sex and diagnosis of trauma.
CONCLUSIONS: The discharge diagnosis of DVT of the lower extremities has significantly increased since 1997. In addition, teenagers with underlying disorders are at highest risk for DVT.

Entities:  

Mesh:

Year:  2008        PMID: 18558189     DOI: 10.1016/j.jpedsurg.2008.02.036

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  34 in total

Review 1.  Lower-extremity venous ultrasound - past, present and future.

Authors:  Rachelle Goldfisher
Journal:  Pediatr Radiol       Date:  2017-08-04

Review 2.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

Review 3.  Identifying patterns of immune-related disease: use in disease prevention and management.

Authors:  Rodney R Dietert; Judith T Zelikoff
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

4.  Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population.

Authors:  Sean Stokes; Patrick Breheny; Aurelia Radulescu; Vlad Calin Radulescu
Journal:  Pediatr Hematol Oncol       Date:  2014-03-31       Impact factor: 1.969

5.  Factors Associated With Documentation of Obesity in the Inpatient Setting.

Authors:  Michelle Katzow; Peter Homel; Kyung Rhee
Journal:  Hosp Pediatr       Date:  2017-12

Review 6.  Current and future management of pediatric venous thromboembolism.

Authors:  Bryce A Kerlin
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

Review 7.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

8.  Childhood obesity: a review of increased risk for physical and psychological comorbidities.

Authors:  Elizabeth R Pulgarón
Journal:  Clin Ther       Date:  2013-01       Impact factor: 3.393

9.  Enoxaparin Dosing and AntiXa Monitoring in Specialty Populations: A Case Series of Renal-Impaired, Extremes of Body Weight, Pregnant, and Pediatric Patients.

Authors:  Tania Ahuja; Katie Mariam Mousavi; Liana Klejmont; Sonya Desai
Journal:  P T       Date:  2018-10

10.  Deep vein thrombosis: thrombolysis in the pediatric population.

Authors:  Lindsey A Greene; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.